NCT04999332View on ClinicalTrials.gov

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Gastric CancerGastric AdenocarcinomaEffects of ChemotherapyToxicity Due to Chemotherapy
Interventions
DRUG

leucovorin, oxaliplatin, docetaxel, S-1

Perioperative chemotherapy with LOTS

Trial Locations (4)

112

NOT_YET_RECRUITING

Taipei Veterans General Hospital, Taipei

404

NOT_YET_RECRUITING

China Medical University Hospital, Taichung

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

813

RECRUITING

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

collaborator

TTY Biopharm

INDUSTRY

collaborator

Kaohsiung Veterans General Hospital.

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

China Medical University Hospital

OTHER